Your browser doesn't support javascript.
loading
Serine peptidase inhibitor Kazal type 1 (SPINK1) as novel downstream effector of the cadherin-17/ß-catenin axis in hepatocellular carcinoma.
Shek, Felix H; Luo, Ruibang; Lam, Brian Y H; Sung, Wing Kin; Lam, Tak-Wah; Luk, John M; Leung, Ming Sum; Chan, Kin Tak; Wang, Hector K; Chan, Chung Man; Poon, Ronnie T; Lee, Nikki P.
Afiliación
  • Shek FH; Department of Surgery, The University of Hong Kong, Faculty of Medicine Building, 21 Sassoon Road, Pokfulam, Hong Kong.
  • Luo R; Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Zhejiang University, Hangzhou, 310003, China.
  • Lam BYH; Department of Computer Science, The University of Hong Kong, Pokfulam, Hong Kong.
  • Sung WK; Wellcome Trust-MRC Institute of Metabolic Science, Addenbrooke's Hospital, University of Cambridge Metabolic Research Laboratories, Cambridge, CB2 0QQ, UK.
  • Lam TW; School of Computing, National University of Singapore, Singapore, Singapore.
  • Luk JM; Computational and Systems Biology, Genome Institute of Singapore, Singapore, 138672, Singapore.
  • Leung MS; Department of Computer Science, The University of Hong Kong, Pokfulam, Hong Kong.
  • Chan KT; Department of Surgery, The University of Hong Kong, Faculty of Medicine Building, 21 Sassoon Road, Pokfulam, Hong Kong.
  • Wang HK; Department of Surgery, The University of Hong Kong, Faculty of Medicine Building, 21 Sassoon Road, Pokfulam, Hong Kong.
  • Chan CM; Department of Surgery, The University of Hong Kong, Faculty of Medicine Building, 21 Sassoon Road, Pokfulam, Hong Kong.
  • Poon RT; Department of Surgery, The University of Hong Kong, Faculty of Medicine Building, 21 Sassoon Road, Pokfulam, Hong Kong.
  • Lee NP; Department of Surgery, The University of Hong Kong, Faculty of Medicine Building, 21 Sassoon Road, Pokfulam, Hong Kong.
Cell Oncol (Dordr) ; 40(5): 443-456, 2017 Oct.
Article en En | MEDLINE | ID: mdl-28631187

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Cadherinas / Inhibidor de Tripsina Pancreática de Kazal / Carcinoma Hepatocelular / Beta Catenina / Neoplasias Hepáticas Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Cell Oncol (Dordr) Año: 2017 Tipo del documento: Article País de afiliación: Hong Kong

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Cadherinas / Inhibidor de Tripsina Pancreática de Kazal / Carcinoma Hepatocelular / Beta Catenina / Neoplasias Hepáticas Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Cell Oncol (Dordr) Año: 2017 Tipo del documento: Article País de afiliación: Hong Kong